Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Meters Articles

Stylish Diabetes Supply Cases From Myabetic.com
New Study Suggests the Effectiveness of Diabetes Education Paired With Meters With Advanced Features
The Great Lancing Debate
The Lowdown on Downloading
Pepex Trio One-Click Blood Glucose Meter
The Cost of Diabetes
Sanofi-Aventis Announces Coming Release of BGStar and iBGStar Blood Glucose Meters
Glucose Meter Plug-in for iPhone
No BG Deal: Today's Meter Innovations Leave Many Yawning for More
Ten Reasons to Test Your Blood Sugar
Diabetes Health Reference Charts
Blood Glucose Meters Reference Guide (PDF)
Continuous Glucose Monitors Reference Guide (PDF)
Mail Order Reference Guide (PDF)
Mail Order Reference Guide (PDF)
Blood Pressure and Cholesterol Medications Reference Guide (PDF)
Blood Pressure and Cholesterol Medications Reference Guide (PDF)
See All Charts…
Meters Archives
Browse the Meters Archives
Subscribe to the Products RSS Feed
Print | Email | Share | Comments (0)

Roche Offers to Buy Disetronic's Insulin Pump Division


May 1, 2003

Roche, best known for its Accu-Chek family of blood-glucose monitors, made an offer in February 2003 to buy Disetronic's insulin pump division. A decision on the purchase should be finalized in May or June if Disetronic's shareholders accept Roche's tender offer of two nonvoting Roche equity securities and a price of 670 Swiss francs (about $490 U.S. dollars) per share.

The February 2003 edition of Diabetic Investor puts the total price of the deal at $900 million, after Roche sells back Disetronic Injection Systems AG to Disetronic's founder and chairman for $310 million.

Roche says that the deal will make its Diagnostics division a leader in integrated diabetes management. It also believes that its "global presence and experience will provide an optimal platform for further growth in the insulin pump market (including accessories), currently valued at approximately 700 million Swiss francs (about $514 million U.S. dollars), with an average growth rate of 11 percent."

The proposed acquisition is subject to acceptance by at least 80 percent of Disetronic shareholders and to approval by regulatory authorities.

Both companies have their headquarters in Switzerland—Disetronic in Burgdorf and Roche in Basel. Roche also has Roche Diabetes Care facilities in Mannheim, Germany; Indianapolis, Indiana; and Ponce, Puerto Rico.

Categories: Diabetes, Diabetes, Insulin, Insulin Pumps, International, Meters, Type 2 Medications

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - May 1, 2003

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.